Trident Lifeline has released its Q1FY26 earnings presentation.

The company reported a strong start to the financial year with revenue from operations growing 27% year-on-year to ₹19.35 Cr.

EBITDA increased by 20% to ₹5.46 Cr, maintaining a healthy 28% margin.

Profit After Taxes rose 15% year-on-year to ₹3.47 Cr.

The company is a growing pharmaceutical player with a hybrid manufacturing model, focusing on export markets and strategic acquisitions.

Management projects continued growth fueled by organic expansion and a robust pipeline of product registrations, bolstering its global footprint.